Beam stock forecast.

Sector. Producer Manufacturing. Industry. Industrial Machinery. No executives to display. Corporate headquarters. --, --. Find real-time VLD - Velo3D Inc stock quotes, company profile, news and ...NTLA Stock 12 Months Forecast. Based on 19 Wall Street analysts offering 12 month price targets for Intellia Therapeutics in the last 3 months. The average price target is $78.65 with a high forecast of $136.00 and a low forecast of $31.00. The average price target represents a 151.68% change from the last price of $31.25.Price target. 49.67 0.00 0.00%. The 12 analysts offering 1 year price forecasts for BEAM have a max estimate of — and a min estimate of —.Find the latest Dutch Bros Inc. (BROS) stock quote, history, news and other vital information to help you with your stock trading and investing.Dec 1, 2023 · Scores. BEAM has an Altman Z-Score of 1.39 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy. Altman Z-Score. 1.39. Piotroski F-Score. 2. Detailed statistics for Beam Therapeutics Inc. (BEAM) stock, including valuation metrics, financial numbers, share information and more.

Find the latest Ion Beam Applications SA (IBAB.BR) stock quote, history, news and other vital information to help you with your stock trading and investing.Apple Inc () Stock Market info Recommendations: Buy or sell Apple stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Apple share forecasts, stock quote and buy / sell signals below.According to present data Apple's AAPL shares and potentially its market environment have been in a bullish cycle in the last 12 …

A high-level overview of Beam Therapeutics Inc. (BEAM) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.GLBE Stock 12 Months Forecast. $46.11. (31.33% Upside) Based on 9 Wall Street analysts offering 12 month price targets for Global-e Online in the last 3 months. The average price target is $46.11 with a high forecast of $50.00 and a low forecast of $41.00. The average price target represents a 31.33% change from the last price of $35.11.

Beam Therapeutics Stock Forecast Over the next 52 weeks, Beam Therapeutics has on average historically fallen by 0.2% based on the past 3 years of stock performance. Beam Therapeutics has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67% BEEM Stock 12 Months Forecast. $24.00. (228.09% Upside) Based on 6 Wall Street analysts offering 12 month price targets for Beam Global in the last 3 months. The average price target is $24.00 with a high forecast of $40.00 and a low forecast of $12.00. The average price target represents a 228.09% change from the last price of $7.32.Next reporting date. February 13, 2024. EPS forecast (this quarter) -$0.20. Annual revenue (last year) $185.3M. Annual profit (last year) -$200.2M. Net profit margin.According to the issued ratings of 11 analysts in the last year, the consensus rating for Beam Therapeutics stock is Hold based on the current 6 hold ratings and 5 buy ratings for BEAM. The average twelve-month price prediction for Beam Therapeutics is $48.80 with a high price target of $105.00 and a low price target of $20.00. Learn more on ...Complete Beam Global stock information by Barron's. View real-time BEEM stock price and news, along with industry-best analysis.

BEEM stock forecast for 2023 – 2027. Last updated: November 25, 2023. BEEM. Beam Global. 5.85 D 4.84% (0.27) Are you interested in Beam Global stocks prediction? If yes, then on this page you will find useful information about the dynamics of the BEEM stock price in 2022-2027. Is BEEM a good long term stock? When should I …

Great weather can motivate you to get out of the house, while inclement weather can make you feel lethargic. When the weather’s great we want to be outside enjoying it. For the best regional weather forecasts check out AccuWeather.

(See BEAM stock forecast) CareDx, Inc . The next Wood-endorsed stock also belongs in the healthcare sector, although it offers a different value proposition. CareDx is a commercial-stage ...Nov 29, 2023 · According to 9 stock analysts, the average 12-month stock price forecast for BEAM stock stock is $55.22, which predicts an increase of 93.14%. The lowest target is $32 and the highest is $105. On average, analysts rate BEAM stock stock as a buy. According to the issued ratings of 11 analysts in the last year, the consensus rating for Beam Therapeutics stock is Hold based on the current 6 hold ratings and 5 buy ratings for BEAM. The average twelve-month price prediction for Beam Therapeutics is $48.80 with a high price target of $105.00 and a low price target of $20.00. Learn more on ...If implemented, the project could extend online connectivity to thousands of people across Kenya. Google is in talks with telecom operators in Kenya to bring balloon-powered internet to people in rural and remote areas. Through its Project ...Lockheed Martin (NYSE:LMT) pays an annual dividend of $12.00 per share and currently has a dividend yield of 2.69%. The company has been increasing its dividend for 21 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 43.84%.Find real-time NIO - NIO Inc stock quotes, company profile, news and forecasts from CNN Business.

Dec 1, 2023 · Scores. BEAM has an Altman Z-Score of 1.39 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy. Altman Z-Score. 1.39. Piotroski F-Score. 2. Detailed statistics for Beam Therapeutics Inc. (BEAM) stock, including valuation metrics, financial numbers, share information and more. See the latest Beam Therapeutics Inc stock price (BEAM:XNAS), related news, valuation, dividends and more to help you make your investing decisions.The 12 analysts offering 1 year price forecasts for BEAM have a max estimate of — and a min estimate of —. Analyst rating Based on 14 analysts giving stock ratings to BEAM in …Ginkgo Bioworks Holdings Stock Forecast. All Analysts Top Analysts Stock Price Forecast. According to 2 stock analysts, the average 12-month stock price forecast for DNA stock stock is $1.88, which predicts an increase of 45.74%. The lowest target is $1.25 and the highest is $2.50.Find the latest Ginkgo Bioworks Holdings, Inc. (DNA) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term ...

Dec 1, 2023 · Scores. BEAM has an Altman Z-Score of 1.39 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy. Altman Z-Score. 1.39. Piotroski F-Score. 2. Detailed statistics for Beam Therapeutics Inc. (BEAM) stock, including valuation metrics, financial numbers, share information and more.

Forecasted world HRC benchmark steel price for 2023. After demand for steel dropped during the arrival of the COVID-19 pandemic in 2019, steel prices also took a hit. However, in 2021, hot-rolled ...Nov 18, 2023 · Future criteria checks 1/6. Beam Therapeutics's earnings are forecast to decline at 11.2% per annum while its annual revenue is expected to grow at 12.2% per year. EPS is expected to decline by 3.5% per annum. Return on equity is forecast to be -82.9% in 3 years. Nov 29, 2023 · The Beam Global stock price fell by -1.95% on the last day (Wednesday, 29th Nov 2023) from $6.14 to $6.02. During the last trading day the stock fluctuated 9.27% from a day low at $6.01 to a day high of $6.57. The price has fallen in 7 of the last 10 days and is down by -17.53% for this period. Volume fell on the last day along with the stock ... Beam Therapeutics Stock Chart and Share Price Forecast, Short-Term "BEAM" Stock Prediction for Next Days and Weeks Walletinvestor.com Beam Therapeutics Inc (BEAM) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024Global whiskey market: leading brands based on sales volume 2022. In 2022, some 30.8 million 9 liter cases of McDowell's No. 1 whiskey were sold worldwide. Royal Stag was number two that year ...Beam Therapeutics Inc Stock Price History. Beam Therapeutics Inc’s price is currently down 1.73% so far this month. During the month of April, Beam Therapeutics Inc’s stock price has reached a high of $32.82 and a low of $28.62. Over the last year, Beam Therapeutics Inc has hit prices as high as $73.27 and as low as $27.77. Year to date ...Earnings vs Market: BEEM is forecast to become profitable over the next 3 years, which is considered above average market growth. High Growth Earnings: BEEM is expected to become profitable in the next 3 years. Revenue vs Market: BEEM's revenue (24.5% per year) is forecast to grow faster than the US market (7.7% per year).Find the latest Ginkgo Bioworks Holdings, Inc. (DNA) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term ...

According to 4 analyst offering 12-month price targets in the last 3 months, Beam Therapeutics has an average price target of $70.25 with a high of $105.00 and a low of $37.00. Below is a summary ...

Find real-time ROKU - Roku Inc stock quotes, company profile, news and forecasts from CNN Business.

REINHARDT KRAUSE. 12:05 PM ET 10/25/2023. The best 5G stocks will evolve over time as business services delivered via cloud computing add new opportunities for wireless firms. But the 5G ...View the latest Beam Therapeutics Inc. (BEAM) stock price, news, historical charts, analyst ratings and financial information from WSJ. Jun 13, 2022 - Beam Therapeutics stock forecast & analyst price target predictions based on 9 analysts offering 12-months price targets for BEAM in the last 3 months. Pinterest. Today. Watch. Shop. Explore. When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with ...Find real-time EDIT - Editas Medicine Inc stock quotes, company profile, news and forecasts from CNN Business.See the latest Beam Therapeutics Inc stock price (BEAM:XNAS), related news, valuation, dividends and more to help you make your investing decisions.NTLA Stock 12 Months Forecast. Based on 19 Wall Street analysts offering 12 month price targets for Intellia Therapeutics in the last 3 months. The average price target is $78.65 with a high forecast of $136.00 and a low forecast of $31.00. The average price target represents a 151.68% change from the last price of $31.25.Average 51.83 75.87% Upside Low 19.00 -35.53% Downside High 95.00 222.36% Upside Broker Rating Beam Therapeutics Inc. currently has an average brokerage recommendation (ABR) of 1.86 on a scale of...

Find real-time DOCU - DocuSign Inc stock quotes, company profile, news and forecasts from CNN Business.Find the latest Dutch Bros Inc. (BROS) stock quote, history, news and other vital information to help you with your stock trading and investing.On average, analysts forecast that MSFT's EPS will be $11.13 for 2024, with the lowest EPS forecast at $10.83, and the highest EPS forecast at $11.55. On average, analysts forecast that MSFT's EPS will be $12.71 for 2025, with the lowest EPS forecast at $12.05, and the highest EPS forecast at $13.38.Beam Therapeutics Stock Forecast Over the next 52 weeks, Beam Therapeutics has on average historically fallen by 0.2% based on the past 3 years of stock performance. Beam Therapeutics has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%Instagram:https://instagram. xlre holdingscurrent interest rates on i bondsbuy gamestop stocksfaln etf Nov 29, 2023 · Beam Therapeutics (BEAM) Stock Price, News & Analysis $29.47 +1.52 (+5.44%) (As of 05:07 PM ET) Compare Today's Range $28.28 $29.84 50-Day Range $17.69 $30.76 52-Week Range $16.95 $51.60 Volume 1.35 million shs Average Volume 986,767 shs Market Capitalization $2.40 billion P/E Ratio N/A Dividend Yield N/A Price Target $48.80 catapillar stockinstant bank account with virtual debit card The average Beam Therapeutics stock price prediction forecasts a potential upside of 52.06% from the current BEAM share price of $27.95. What is BEAM's forecast return on equity (ROE) for 2023-2026? ( NASDAQ : BEAM ) forecast ROE is N/A , which is considered weak . ishares growth etf View the latest Beam Therapeutics Inc. (BEAM) stock price, news, historical charts, analyst ratings and financial information from WSJ. Find the latest Teladoc Health, Inc. (TDOC) stock quote, history, news and other vital information to help you with your stock trading and investing.7 brokers have issued 12-month price objectives for Sangamo Therapeutics' shares. Their SGMO share price targets range from $1.00 to $10.00. On average, they expect the company's stock price to reach $4.68 in the next twelve months. This suggests a possible upside of 1,150.3% from the stock's current price. View analysts price targets …